Multisystem inflammatory syndrome in a fully vaccinated 18-year-old without known SARS-CoV-2 infection
Authors:
Open Access
- 1 September 2022
- journal article
- case report
- Published by Springer Nature in Pediatric Rheumatology
- Vol. 20 (1) , 1-5
Abstract
Background: Multisystem inflammatory syndrome in children (MIS-C) is a febrile syndrome that is observed in the pediatric population following severe acute respiratory syndrome 2 (SARS-CoV-2) infection. Vaccines have prevented or lessened the severity of the initial acute respiratory infection, while their effectiveness against severe MIS-C is just beginning to be reported. Case presentation: Here we report a fully vaccinated teenage female with no known history of SARS-CoV-2 infection who presented with shock and heart failure. Her presentation was initially thought secondary to a retropharyngeal abscess but was later identified as MIS-C after confirmed nucleocapsid antibody. Conclusions: Given the recent Omicron waves, the ongoing international outbreaks with evolving variants and the continued evolution of the COVID-19 pandemic, this case emphasizes the need to include MIS-C in the differential diagnosis, even in a fully vaccinated, previously healthy child.Keywords
All Related Versions
This publication has 10 references indexed in Scilit:
- Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12–18 Years — United States, July–December 2021MMWR. Morbidity and Mortality Weekly Report, 2022
- Multisystem Inflammatory Syndrome in Children After Breakthrough Infection in a COVID-19–vaccinated ChildThe Pediatric Infectious Disease Journal, 2021
- Multisystem Inflammatory Syndrome in a Previously Vaccinated Adolescent Female With Sickle Cell DiseaseThe Pediatric Infectious Disease Journal, 2021
- Multisystem inflammatory syndrome after SARS-CoV-2 vaccination (MIS-V), to interpret with cautionPostgraduate Medical Journal, 2021
- Trends in Geographic and Temporal Distribution of US Children With Multisystem Inflammatory Syndrome During the COVID-19 PandemicJAMA Pediatrics, 2021
- Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in AdolescentsNew England Journal of Medicine, 2021
- Retropharyngeal Edema and Neck Pain in Multisystem Inflammatory Syndrome in Children (MIS-c)Journal of the Pediatric Infectious Diseases Society, 2021
- Incidence of Multisystem Inflammatory Syndrome in Children Among US Persons Infected With SARS-CoV-2JAMA Network Open, 2021
- Multisystem Inflammatory Syndrome in Children in a 15-Year-Old Male with a Retropharyngeal PhlegmonCase Reports in Pediatrics, 2020
- Multisystem Inflammatory Syndrome in U.S. Children and AdolescentsNew England Journal of Medicine, 2020